August 22, 2014 6:35 AM ET

Pharmaceuticals

Company Overview of Ember Therapeutics, Inc.

Executive Profile

Jeffrey Saunders Ph.D.

Head of Chemistry, Agios Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Jeffrey Saunders, Jeff, Ph.D has been Vice President of Small Molecule Drug Discovery at Ember Therapeutics, Inc. since May 2012. Dr. Saunders served as Head/Vice president of Chemistry at Agios Pharmaceuticals Inc. since his joining in September 2008. Prior to joining Agios, Dr. Saunders worked as a consultant at Elixir Pharmaceuticals Inc., where he managed all chemistry and related intellectual property for 5 years, and as a consultant for Agios for one and a ...

Corporate Headquarters

29 Newbury Street
Boston, Massachusetts 02116

United States

Phone: 617-585-2000
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
University of South Carolina
BA
Hope College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ember Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.